The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands of the NR2B receptor and may be useful for the treatment of various disorders of the central nervous system.
该披露通常涉及到式I的化合物,包括它们的盐,以及使用这些化合物的组合物和方法。这些化合物是NR2B受体的
配体,可能对中枢神经系统的各种疾病的治疗有用。